@article{1ce3c707fff742cbad871713430a9af8,
title = "Clinical and economic burden of severe asthma among US patients treated with biologic therapies",
keywords = "Humans, Middle Aged, Anti-Asthmatic Agents/economics, Cost of Illness, Male, Asthma/drug therapy, Young Adult, Adolescent, Adult, Antibodies, Monoclonal, Humanized/economics, Female, Aged, Biological Therapy/economics, Retrospective Studies, Biological Products/economics, Child, Omalizumab/economics",
author = "Joan Reibman and Laren Tan and Chris Ambrose and Yen Chung and Pooja Desai and Llanos, \{Jean Pierre\} and Meghan Moynihan and Joseph Tkacz",
note = "Publisher Copyright: {\textcopyright} 2021 The Authors",
year = "2021",
month = sep,
doi = "10.1016/j.anai.2021.03.015",
language = "English",
volume = "127",
pages = "318--325.e2",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
number = "3",
}